Back to Search
Start Over
Medicenna To Host Key Opinion Leader Call Focused on Latest MDNA55 Recurrent Glioblastoma Phase 2b Clinical Study Results
- Source :
- Plus Company Updates. November 21, 2019
- Publication Year :
- 2019
-
Abstract
- TORONTO: Medicenna Therapeutics Corp.has issued the following press release: Medicenna Therapeutics Corp. ('Medicenna' or 'the Company') (TSX: MDNA,OTCQB: MDNAF), a clinical stage Immuno-Oncology company, today announced that it will host [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.606406053